NOVOCURE LTD: FDA APPROVES OPTUNE LUA FOR CONCURRENT USE WITH PD-1/PD-L1 INHIBITORS FOR TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER

Reuters · 10/15 20:08

Please log in to view news